Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlucoTrack, Inc.

5.65
-0.0700-1.22%
Post-market: 5.650.00000.00%19:53 EDT
Volume:118.89K
Turnover:688.50K
Market Cap:3.06M
PE:0.00
High:5.78
Open:5.69
Low:5.56
Close:5.72
Loading ...

GlucoTrack announces repurchase of Series A warrants

TIPRANKS
·
08 Jul

GlucoTrack Inc. Repurchases Over 90% of Series A Warrants

Reuters
·
08 Jul

GlucoTrack Announces Repurchase of Series a Warrants

THOMSON REUTERS
·
08 Jul

Exclusive: Former Lockton exec Taiym joining life insurance tech firm Integrity as global COO

Reuters
·
30 Jun

GlucoTrack Stock (GCTK) Stock Rockets 130% on Diabetes Tracking Data

TIPRANKS
·
25 Jun

GlucoTrack Inc trading halted, volatility trading pause

TIPRANKS
·
25 Jun

GlucoTrack Inc. Announces Positive First-In-Human Study Results for Innovative Continuous Blood Glucose Monitor at ADA's 85th Scientific Sessions

Reuters
·
25 Jun

GlucoTrack and Onetwo Analytics Present Positive Final Results of First-in-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85TH Scientific Sessions

THOMSON REUTERS
·
25 Jun

GlucoTrack Inc. Announces 1:60 Reverse Stock Split Effective June 13, 2025

Reuters
·
16 Jun

GlucoTrack Inc trading halted, news pending

TIPRANKS
·
14 Jun

GlucoTrack announces 1-for-60 reverse stock split

TIPRANKS
·
12 Jun

GlucoTrack Announces Reverse Stock Split Shareholder Approved Action Meets Nasdaq Panel Hearing Listing Requirements

THOMSON REUTERS
·
12 Jun

GlucoTrack Inc - 1-for-60 Reverse Stock Split Effective June 16, 2025

THOMSON REUTERS
·
12 Jun

GlucoTrack Inc. Unveils Promising Results from First-In-Human Trial of Implantable Continuous Blood Glucose Monitor at ADA Scientific Sessions

Reuters
·
04 Jun

GlucoTrack Strengthens Board of Directors With Election of Victoria E. Carr-Brendel, Phd

THOMSON REUTERS
·
28 May

Press Release: Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Dow Jones
·
28 May

GlucoTrack Inc. Q1 2025 Results: Cash Position Increases to $9.1 Million, Driven by $6.4 Million from Financing Activities

Reuters
·
15 May

GlucoTrack Q1 EPS $(0.67) Up From $(11.73) YoY

Benzinga
·
15 May

BRIEF-Glucotrack Reports First Quarter 2025 Financial Results And Recent Corporate Highlights

Reuters
·
15 May

GlucoTrack Inc - FDA Ide Approval for GlucoTrack Cbgm Expected in Q4 2025

THOMSON REUTERS
·
15 May